Altogether, we have shown that expression of ELF4 varies across tumours of the 32 cancer types investigated and that there is a link between the expression levels of ELF4 in tumours to the age of patients, the mutation burden, and the clinical outcomes. This evidence concerns the gene ELF4 and neoplasm.